Published in Cancer Weekly, September 29th, 1997
Immunization requires the introduction of an antigen coupled with an adjuvant which stimulates a required inflammatory reaction to boost the host's immune response. Dendritic cells have been termed "nature's adjuvant" as they are the most potent naturally-occurring, T-cell stimulating, accessory cell. They are attractive adjuvant candidates for vaccine-based immunotherapy because of their potential to function as natural adjuvants for poorly immunogenic proteins derived from microbes or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.